Conformational stability and activity analysis of two hydroxymethylbilane synthase mutants, K132N and V215E, with different phenotypic association with acute intermittent porphyria

Схожие документы

• A Pharmacological Chaperone Therapy for Acute Intermittent Porphyria
  по: Bustad, Helene J., et al.
  Опубликовано: (2020)
• Acute Intermittent Porphyria: An Overview of Therapy Developments and Future Perspectives Focusing on Stabilisation of HMBS and Proteostasis Regulators
  по: Bustad, Helene J., et al.
  Опубликовано: (2021)
• Identification and expression of mutations in the hydroxymethylbilane synthase gene causing acute intermittent porphyria (AIP).
  по: Solis, C., et al.
  Опубликовано: (1999)
• Identification and Characterization of 40 Novel Hydroxymethylbilane Synthase Mutations that Cause Acute Intermittent Porphyria
  по: Chen, Brenden, et al.
  Опубликовано: (2019)
• Feline acute intermittent porphyria: a phenocopy masquerading as an erythropoietic porphyria due to dominant and recessive hydroxymethylbilane synthase mutations
  по: Clavero, Sonia, et al.
  Опубликовано: (2010)